{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:59:25Z","timestamp":1789545565750,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejim.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T20:45:55Z","timestamp":1488401155000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Kidney disease and venous thromboembolism: Does being woman make the difference?"],"prefix":"10.1016","volume":"39","author":[{"given":"A","family":"Gigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pierucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FS","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Napoleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.02.012_bb0005","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.02.012_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ckj\/sfv014","article-title":"Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report","volume":"8","author":"Pippias","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2017.02.012_bb0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.02.012_bb0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.genm.2008.03.002","article-title":"Gender and human chronic renal disease","volume":"5","author":"Silbiger","year":"2008","journal-title":"Gender Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2015.05.001","article-title":"US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0035","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/j.jvs.2012.10.117","article-title":"Chronic kidney disease and dialysis access in women","volume":"57","author":"Pounds","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejim.2017.02.012_bb0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jarr.2003.50001","article-title":"The role of gender in the progression of renal disease","volume":"10","author":"Silbiger","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.ejim.2017.02.012_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","article-title":"Effect of gender on the progression of nondiabetic renal disease: a meta-analysis","volume":"11","author":"Neugarten","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0060","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.genm.2008.03.010","article-title":"Estrogens and the diabetic kidney","volume":"5","author":"Maric","year":"2008","journal-title":"Gender Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0065","doi-asserted-by":"crossref","first-page":"F680","DOI":"10.1152\/ajprenal.90505.2008","article-title":"Sex, diabetes and the kidney","volume":"296","author":"Maric","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ki.2008.200","article-title":"Gender differences in predictors of the decline of renal function in the general population","volume":"74","author":"Halbesma","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.1996.111","article-title":"Risk of developing end-stage renal disease in a cohort of mass screening","volume":"49","author":"Iseki","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/sj.ki.5001794","article-title":"Predicting initiation and progression of chronic kidney disease: developing renal risk scores","volume":"70","author":"Taal","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI117531","article-title":"Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor","volume":"94","author":"Baylis","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2017.02.012_bb0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ki.2008.261","article-title":"Gender differences in chronic kidney disease","volume":"74","author":"Iseki","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004802","article-title":"Human and murine kidneys show gender- and species-specific gene expression differences in response to injury","volume":"4","author":"Si","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2017.02.012_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ki.5000058","article-title":"The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age","volume":"69","author":"Eriksen","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2004.09.022","article-title":"The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination","volume":"45","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","article-title":"The nephrotic syndrome","volume":"338","author":"Orth","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2017.02.012_bb0125","first-page":"1129","article-title":"Nephrotic syndrome in adults: diagnosis and management","volume":"80","author":"Kodner","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ejim.2017.02.012_bb0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2017.02.012_bb0140","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/asheducation.V2012.1.168.3798232","article-title":"Hemostatic defects in liver and renal dysfunction","volume":"2012","author":"Mannucci","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejim.2017.02.012_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.123","article-title":"Cardio-Kidney-Damage: a unifying concept","volume":"78","author":"El Nahas","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0272-6386(99)70222-2","article-title":"Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin","volume":"33","author":"Wiesholzer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.108.4.978","article-title":"Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy","volume":"108","author":"Stein","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2017.02.012_bb0170","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/CIRCULATIONAHA.112.113944","article-title":"Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts","volume":"126","author":"Mahmoodi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.02.012_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0180","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.565","article-title":"Microalbuminuria and risk of venous thromboembolism","volume":"301","author":"Mahmoodi","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2017.02.012_bb0185","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2010.04048.x","article-title":"Chronic kidney disease stages 1\u20133 increase the risk of venous thrombosis","volume":"8","author":"Ocak","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0190","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12652","article-title":"Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"12","author":"Christiansen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2003.08.047","article-title":"Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States","volume":"43","author":"Abbott","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0200","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2017.02.012_bb0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","article-title":"Venous thromboembolism in patients hospitalized with nephrotic syndrome","volume":"121","author":"Kayali","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","article-title":"Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study","volume":"155","author":"Kerlin","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2017.02.012_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0225","first-page":"104","article-title":"Congenital nephrotic syndrome: a clinico-pathologic study of thirty children","volume":"14","author":"Hamed","year":"2001","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thrombo-embolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2017.02.012_bb0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.02.012_bb0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0030-1248722","article-title":"Disorders of hemostasis associated with chronic kidney disease","volume":"36","author":"Jalal","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1076-7460.2004.02125.x","article-title":"Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study","volume":"13","author":"Shlipak","year":"2004","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.ATV.16.3.455","article-title":"Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria","volume":"16","author":"Kario","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-5491.1994.tb00311.x","article-title":"Prothrombin fragment 1 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients","volume":"11","author":"Gruden","year":"1994","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0260","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diab.43.3.426","article-title":"PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria","volume":"43","author":"Gruden","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2017.02.012_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/cs0970037","article-title":"Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study","volume":"97","author":"Clausen","year":"1999","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ejim.2017.02.012_bb0270","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1053\/ajkd.2002.32774","article-title":"Chronic dialysis patients have high risk for pulmonary embolism","volume":"39","author":"Tveit","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0275","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1111\/j.1538-7836.2011.04525.x","article-title":"The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria","volume":"9","author":"Mahmoodi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00467-002-0865-7","article-title":"Surface markers of platelet function in idiopathic nephritic syndrome in children","volume":"17","author":"Tkaczyk","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2017.02.012_bb0290","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(03)00913-2","article-title":"Utility of in vitro closure time test for evaluating platelet related primary hemostasis in dialysis patients","volume":"42","author":"Zupan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.02.012_bb0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","article-title":"Meta-analysis: low molecular-weight heparin and bleeding in patients with severe renal insufficiency","volume":"144","author":"Lim","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2174\/157016111203140518172048","article-title":"Hypercoagulability and nephrotic syndrome","volume":"12","author":"Gigante","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1440-1797.2007.00890.x","article-title":"Adult nephrotic syndrome: non-specific strategies for treatment","volume":"13","author":"Charlesworth","year":"2008","journal-title":"Nephrology"},{"key":"10.1016\/j.ejim.2017.02.012_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.02.012_bb0315","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCP.0b013e32832ee371","article-title":"Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms","volume":"15","author":"Wattanakit","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0320","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.02.012_bb0325","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfu080","article-title":"Anticoagulation in chronic kidney disease patients-the practical aspects","volume":"7","author":"Hughes","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2017.02.012_bb0330","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.semnephrol.2005.06.011","article-title":"Coagulation disorders in uremia","volume":"26","author":"Molino","year":"2006","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0335","doi-asserted-by":"crossref","first-page":"f5133","DOI":"10.1136\/bmj.f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2017.02.012_bb0340","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000064282","article-title":"Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests","volume":"91","author":"Sirolli","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2017.02.012_bb0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1982.tb03862.x","article-title":"Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephritic syndrome","volume":"52","author":"Jackson","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0350","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ki.1984.72","article-title":"The metabolism of arachidonic acid by platelets in nephrotic syndrome","volume":"25","author":"Schieppati","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0049-3848(79)90082-3","article-title":"Platelet hyperaggregability and the nephrotic syndrome","volume":"16","author":"Remuzzi","year":"1979","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2017.02.012_bb0360","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jth.12891","article-title":"PACAP deficiency associated with increased platelet count and aggregability in nephrotic syndrome","volume":"13","author":"Eneman","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0365","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2017.02.012_bb0370","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH07-02-0115","article-title":"Circulating P-selectin and the risk of recurrent venous thromboembolism","volume":"97","author":"Kyrle","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0375","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1987.73","article-title":"Clinical correlation between hypercoagulability and thrombo-embolic phenomena","volume":"31","author":"Robert","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.02.012_bb0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpneph0421","article-title":"Evidence-based treatment recommendations for uremic bleeding","volume":"3","author":"Hedges","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0385","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0390","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0395","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","article-title":"Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California","volume":"128","author":"White","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ejvs.2002.1778","article-title":"Incidence of diagnosed deep vein thrombosis in the general population: systematic review","volume":"25","author":"Fowkes","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejim.2017.02.012_bb0405","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccm.2004.01.013","article-title":"Sex and gender issues and venous thromboembolism","volume":"25","author":"Moores","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0410","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2004.11.023","article-title":"Risk of venous thromboembolic disease in women: a qualitative systematic review","volume":"121","author":"Romero","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0415","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM198603273141305","article-title":"Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study","volume":"314","author":"Huisman","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0420","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0741-5214(95)70034-X","article-title":"Gender bias in use of venous ultrasonography for diagnosis of deep venous thrombosis","volume":"22","author":"Beebe","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejim.2017.02.012_bb0425","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0430","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejim.2010.03.013","article-title":"Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow up study","volume":"21","author":"Severinsen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0435","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","article-title":"Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis","volume":"368","author":"McRae","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.02.012_bb0440","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11255-013-0574-0","article-title":"Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters","volume":"46","author":"Ismail","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0445","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor \u03b1","volume":"120","author":"Val\u00e9ra","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2017.02.012_bb0450","doi-asserted-by":"crossref","DOI":"10.1210\/en.2015-1522","article-title":"Protective hematopoietic impact of estrogens in a mouse model of thrombosis: respective roles of nuclear vs membrane estrogen receptor \u03b1","author":"Val\u00e9ra","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2017.02.012_bb0455","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1160\/TH11-07-0481","article-title":"Haemostatic variables during normal menstrual cycle. A systematic review","volume":"107","author":"Knol","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0460","article-title":"Clotting factor changes during the first cycle of oral contraceptive use","author":"Westhoff","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.ejim.2017.02.012_bb0465","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism\u2014results from a randomized, double-blind, clinical trial","volume":"85","author":"Hoibraaten","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0470","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1538-7836.2010.03930.x","article-title":"17\u03b1-ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor \u03b1","volume":"8","author":"Cleuren","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0475","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa041533","article-title":"Electronic alerts to prevent venous thromboembolism among hospitalized patients","volume":"352","author":"Kucher","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.02.012_bb0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1076029606296392","article-title":"An evaluation of venous thromboembolic risk in acutely ill medical patients immobilized at home: the AT-HOME Study","volume":"13","author":"Haas","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0485","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2003.09.057","article-title":"A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis","volume":"93","author":"Goldhaber","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.02.012_bb0490","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1538-7836.2006.01818.x","article-title":"Identifying acutely ill medical patients requiring thromboprophylaxis","volume":"4","author":"Chopard","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0495","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1160\/TH08-05-0337","article-title":"Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients","volume":"100","author":"Lecumberri","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0500","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1160\/TH05-06-0385","article-title":"Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients","volume":"94","author":"Cohen","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0505","first-page":"64","article-title":"An electronic tool for venous thromboembolism prevention in medical and surgical patients","volume":"91","author":"Samama","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2017.02.012_bb0510","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0515","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.02.012_bb0520","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517300742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517300742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:29:46Z","timestamp":1719084586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517300742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":104,"alternative-id":["S0953620517300742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.02.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney disease and venous thromboembolism: Does being woman make the difference?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}